Co-Diagnostics (CODX) Loans and Notes Receivables (2021 - 2023)
Historic Loans and Notes Receivables for Co-Diagnostics (CODX) over the last 3 years, with Q3 2023 value amounting to $18750.0.
- Co-Diagnostics' Loans and Notes Receivables fell 7500.0% to $18750.0 in Q3 2023 from the same period last year, while for Sep 2023 it was $18750.0, marking a year-over-year decrease of 7500.0%. This contributed to the annual value of $75000.0 for FY2022, which is 0.0% changed from last year.
- According to the latest figures from Q3 2023, Co-Diagnostics' Loans and Notes Receivables is $18750.0, which was down 7500.0% from $37500.0 recorded in Q2 2023.
- In the past 5 years, Co-Diagnostics' Loans and Notes Receivables ranged from a high of $75000.0 in Q4 2021 and a low of $18750.0 during Q3 2023
- Moreover, its 3-year median value for Loans and Notes Receivables was $56250.0 (2021), whereas its average is $53618.8.
- The largest annual percentage gain for Co-Diagnostics' Loans and Notes Receivables in the last 5 years was 653.41% (2023), contrasted with its biggest fall of 7500.0% (2023).
- Over the past 3 years, Co-Diagnostics' Loans and Notes Receivables (Quarter) stood at $75000.0 in 2021, then changed by 0.0% to $75000.0 in 2022, then crashed by 75.0% to $18750.0 in 2023.
- Its last three reported values are $18750.0 in Q3 2023, $37500.0 for Q2 2023, and $37500.0 during Q1 2023.